Related Experiment Video

Updated: Jun 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients

Yuko Ohta1, Takuya Tsuchihashi, Uran Onaka

  • 1Division of Hypertension, Clinical Research Institute, National Kyushu Medical Center, Fukuoka. yukoo@kyumed.jp

Internal Medicine (Tokyo, Japan)
|August 6, 2010
PubMed

Insights

Most treated hypertensive patients have multiple cardiovascular risk factors, often requiring more medications. Integrated management of blood pressure and comorbid conditions is crucial for better outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Hypertension frequently coexists with metabolic syndrome components, chronic kidney disease (CKD), and hyperuricemia.
  • The clustering of these cardiovascular risk factors can synergistically increase morbidity.
  • Understanding risk factor aggregation is vital for managing hypertensive patients.

Purpose of the Study:

  • To assess the clustering of cardiovascular risk factors in treated hypertensive patients.
  • To evaluate the relationship between risk factor burden and blood pressure control.
  • To identify the prevalence of comorbidities in this patient population.

Main Methods:

  • A study of 699 treated hypertensive patients at National Kyushu Medical Center, Japan.
  • Assessment of blood pressure control and comorbidities including obesity, diabetes mellitus (DM), dyslipidemia, CKD, and hyperuricemia.
  • Analysis of the number of cardiovascular risk factors per patient.

Main Results:

  • The average number of cardiovascular risk factors was 1.5 per patient.
  • 18.7% of patients had no comorbid risk factors, while 18.2% had three or more.
  • Patients with three or more risk factors required more antihypertensive drugs and had poorer metabolic and kidney function markers.

Conclusions:

  • The majority of treated hypertensive patients have multiple coexisting cardiovascular risk factors.
  • Clustering of risk factors necessitates a higher number of antihypertensive medications.
  • Integrated management strategies for blood pressure and comorbid conditions are recommended.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...